期刊
BRAIN SCIENCES
卷 13, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/brainsci13040548
关键词
glioma; CDKN2A; B homozygous deletion; radiomics; survival analysis; MRI
This study aimed to develop a predictive model for CDKN2A/B homozygous deletion in gliomas and investigate the prognostic value of this biomarker and radiomic features in IDH-mutant LGGs. The results showed that radiomic features accurately predict CDKN2A/B homozygous deletion, and CDKN2A/B homozygous deletion can be used as an independent predictor of prognosis in LGGs.
Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) homozygous deletion was a significant prognostic factor for gliomas and affected the treatment strategy. However, the radiomic features of CDKN2A/B homozygous deletion in gliomas have not been developed, and whether the radiomic features and molecular subgroups can provide prognostic value in low-grade gliomas (LGGs) has yet to be studied. Thus, this study aimed to develop a predictive model of CDKN2A/B in gliomas and investigate the prognostic value of this biomarker and radiomic features in isocitrate dehydrogenase (IDH)-mutant LGGs. First, we developed the predictive model of CDKN2A/B homozygous deletion in 292 patients. The results revealed that radiomic features predict CDKN2A/B homozygous deletion with high accuracy and reliability. Subsequently, the prognostic survival models of 104 patients (IDH-mutant LGGs) were established, which provided an essential value for prognostic evaluation and indicated that CDKN2A/B homozygous deletion can be used as an independent predictor of prognosis in LGGs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据